Lyndra

Based in Watertown, Massachusetts, this clinical-stage biopharmaceutical company is at the forefront of developing long-acting oral therapies. Their innovative LYNX™ drug delivery platform holds the potential to revolutionize oral therapy by transforming them into weekly or monthly pills, thereby improving patient adherence and outcomes.